About this trial
Phase 0 non-interventional longitudinal study of children and adults with Developmental and Epileptic Encephalopathy (DEE) due to a genetic cause. There are six arms of the study. Arms 1, 2, and 3 are devoted to one example DEE, MEF2C Haploinsufficiency Syndrome (MCHS). Arms 4, 5, and 6 are open to all DEE. Arm 1 (in-person) will enroll children 0 to 15, who will make in-person visits to Weill Cornell Medicine four times over two years. Arm 2 (virtual) will enroll people of all ages and older who will make virtual visits over Weill Cornell Zoom to Weill Cornell Medicine over two years (2 if 16 and older; 4 if 0 to 15). Arm 3 (registry) will enroll people of all ages in an online-only survey. Arms 4 - 6 mirror this structure but they are open to all children with DEE. Arm 4 (in-person) will enroll children of any age, who will make in-person visits every 6 months for 10 years. Arm 5 (virtual) will enroll children of any age for virtual visits, twice a year of 0 to 15, once a year if 16 or older. Arm 6 (registry) will enroll people of all ages in an online only survey.
Eligibility criteria
Qualifiers
Molecular diagnosis of a genetic disorder associated with DEE, as confirmed by the study investigators
A neurological phenotype such as epilepsy or developmental delay as confirmed by the study investigators.
English Speaking (Arms 1, 2, 4, 5). The registries may be completed by people who speak any language.
MEF2C
Disqualifiers
Presence of a significant non-DEE-related central nervous impairment/behavioral disturbance that would confound the scientific rigor or interpretation of results of the study
History of prematurity (defined as gestational age <35 weeks), interventricular hemorrhage, structural brain deficit, or congenital heart disease
Presence of a clinical comorbidity deemed by the investigator to potentially confound the typical presentation of DEE
Trial design
Treatments tested in this trial
- Observation
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Rare Bird Foundation
Collaborator